Both GPI-CDR H3(PG16) and GPI-CDR H3(E51) inhibited HIV-1 pseudotypes expressing envelopes produced from clades A, B, and B with identical examples of potency, whereas for some from the HIV-1 pseudotypes produced from clades BC, C, and AE, GPI-CDR H3(PG16) inhibited infection much better than did GPI-CDR H3(E51)

Posted on by Courtney Roberts

Both GPI-CDR H3(PG16) and GPI-CDR H3(E51) inhibited HIV-1 pseudotypes expressing envelopes produced from clades A, B, and B with identical examples of potency, whereas for some from the HIV-1 pseudotypes produced from clades BC, C, and AE, GPI-CDR H3(PG16) inhibited infection much better than did GPI-CDR H3(E51). Open in another Continue Reading